Search the Newsreel

Algoma Steel Group Inc. Is Maintained at Sector Perform by RBC Capital

RBC Capital has maintained its "Sector Perform" rating for Algoma Steel Group Inc. This indicates that RBC Capital views Algoma Steel's stock as likely to perform in line with the overall sector. The report does not provide additional details regarding the rationale behind this …

Orographic Financial Advisors LLC Invests $1.51 Million in Crown Castle Inc. $CCI

Orographic Financial Advisors LLC has initiated a new position in Crown Castle Inc. (NYSE:CCI), acquiring 18,573 shares valued at approximately $1.51 million. This investment highlights continued institutional interest in Crown Castle, with other major investors also adjusting their holdings. The stock currently offers a …

California State Teachers Retirement System Trims Stock Position in Crown Castle Inc. $CCI

The California State Teachers Retirement System reduced its stake in Crown Castle Inc. by 2.6% in the first quarter, selling 18,952 shares but retaining 711,707 shares valued at $57.9 million. Institutional investors now own 90.77% of the real estate investment trust. Analysts generally have …

Algoma Steel Group Inc. Q2 2026 Earnings: Revenue Falls to C$267.5M - News and Statistics

Algoma Steel Group Inc. reported a significant revenue decline to C$267.5 million in Q2 2026 from C$589.7 million a year earlier, primarily due to reduced steel shipments during its transition to electric arc furnace production. Despite a widening operating loss, the net loss improved, …

Castle Biosciences raises 2026 revenue guidance to $365M-$375M as TissueCypher volume trends toward 50%-52% growth

Earnings Call Insights: Castle Biosciences (CSTL) Q2 2026 MANAGEMENT VIEW * "What a great quarter." (Founder, CEO, President & Director Derek Maetzold) "We delivered revenue of $103.5 million, 20% growth compared to the second quarter of 2025." (CEO Maetzold) * "We believe we will …

Key facts: CSTL Q2 Revenue $103.6M; AdvanceAD-Tx 97.8% Concordance

Castle Biosciences (CSTL) reported Q2 revenue of $103.55 million, exceeding estimates of $86.2 million, despite an operating loss of $3.07 million. Additionally, a study revealed that the company's AdvanceAD-Tx testing for atopic dermatitis showed a 97.8% concordance in systemic therapy decisions, significantly higher than …

Public Notice: Arium Networks (Crown Castle) is proposing to install a new 32.0-foot replacement telecommunications light pole utility structure within the public right of way located at the following site: 10617 West Solano Drive, Glendale, Maricopa County, Ari

Arium Networks, a subsidiary of Crown Castle, is proposing to install a new 32.0-foot telecommunications light pole in Glendale, Arizona. The company is seeking comments from interested parties regarding the potential impact of the project on historical or cultural sites, as well as the …

Castle Biosciences Inc (CSTL) Institutional Confidence

Algoma Steel Posts Q2 Loss but Records Strong Plate Sales as EAF Transition Advances

Castle Biosciences (NASDAQ:CSTL) Releases Quarterly Earnings Results, Beats Expectations By $0.37 EPS

Castle Biosciences (NASDAQ:CSTL) Sees Strong Trading Volume After Earnings Beat

Castle Biosciences, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CSTL)

Castle Biosciences, Inc. released its Q2 2026 earnings call presentation. The company reported an EPS of -$0.07, beating estimates by $0.34, and revenue of $103.55M, an increase of 20.14% year-over-year, beating estimates by $17.30M. This report accompanies their earnings call from July 31, 2026.

Castle Minerals pivots to flagship Côte d’Ivoire gold project and expands WA footprint

Algoma Steel Group Inc. Reports Financial Results for the Three Months Ended June 30, 2026

Algoma Steel Group Inc. reported its financial results for the three months ended June 30, 2026, marking a significant transition to its Electric Arc Furnace (EAF) platform. The company experienced a decline in consolidated revenue and shipments due to the U.S. Section 232 tariffs …

Earnings call transcript: Castle Biosciences tops Q2 2026 estimates, shares jump

Castle Biosciences (CSTL) exceeded second-quarter 2026 profit and revenue estimates, leading to a significant jump in its share price and an increase in full-year sales guidance. The company reported an adjusted loss of 7 cents per share on revenue of $103.5 million, outperforming analyst …

Is Castle Biosciences (CSTL) Undervalued After Q2 Earnings Miss? GF Score: 81/100, Revenue at $103.5 Million

Castle Biosciences Reports Second Quarter 2026 Results

Earnings Flash (CSTL) Castle Biosciences Posts Q2 Adjusted EPS -$0.07, vs. FactSet Est of -$0.41

Castle Biosciences (CSTL) reported Q2 adjusted EPS of -$0.07, significantly outperforming FactSet's estimate of -$0.41. The company also posted Q2 revenue of $103.5 Million, surpassing the FactSet estimate of $86.2 Million. This positive earnings flash comes alongside other recent company news, including Health Department …

Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates

Castle Biosciences, Inc. (CSTL) reported a Q2 loss of $0.07 per share, significantly beating the Zacks Consensus Estimate loss of $0.44 due to non-recurring items. The company also surpassed revenue estimates with $103.55 million, an 18.61% beat, continuing a trend of outperforming revenue expectations …

Royal Bank of Canada Acquires 938,653 Shares of Crown Castle Inc. $CCI

Royal Bank of Canada significantly increased its stake in Crown Castle Inc. (NYSE:CCI) by 28.6% in the first quarter, purchasing 938,653 additional shares. This acquisition brings their total holdings to 4.22 million shares valued at approximately $343.3 million. Institutional investors now collectively own 90.77% …

Edgestream Partners L.P. Grows Position in Crown Castle Inc. $CCI

Edgestream Partners L.P. significantly increased its stake in Crown Castle Inc. (NYSE:CCI) by 18.9% in the first quarter of 2026, bringing its total holdings to $7.79 million. Other institutional investors like Universal Beteiligungs und Servicegesellschaft mbH, Cooke & Bieler LP, and Legal & General …

Algoma Steel Group (NASDAQ:ASTL) Announces Quarterly Earnings Results

Algoma Steel Group Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ASTL) 2026-07-30

What Put Algoma Steel (NASDAQ:ASTL) on NASDAQ Composite Radar?

Algoma continues to struggle in US tariff environment

Algoma Steel Group Inc. reported a net loss of $68 million in Q2 2026, an improvement from the previous year, but shipments are down significantly due to US tariffs and the transition to EAF steelmaking. The company is pivoting to a Canada-centric, plate-first strategy, …

Algoma Steel Group Inc. (ASTL) Reports Q2 Loss, Lags Revenue Estimates

Algoma Steel Group Inc. (ASTL) reported a Q2 loss of $0.64 per share, missing the Zacks Consensus Estimate of a $0.51 loss. The company's revenues for the quarter were $193.24 million, also falling short of the consensus estimate by 8.05% and significantly lower than …

Algoma Steel announces $96-million second-quarter loss

Algoma Steel Group Inc. reported a net loss of $96 million in the second quarter, primarily due to crippling U.S. tariffs, though this was an improvement from the $110.6 million loss in the same period last year. CEO Rajat Marwah highlighted the company's pivot …

Algoma Steel Group (ASTL) Releases Q2 2026 Earnings: Revenue Falls Short and Loss Widens

Algoma Steel Group (ASTL) reported disappointing Q2 2026 earnings, with revenue of $188.3 million falling significantly short of estimates and representing a 56.6% year-over-year decrease. The company posted a widened operating loss of -$94.5 million and a net loss of -$0.62 per diluted share, …

Algoma Steel 2Q Rev C$267.5M >ASTL

This article reports that Algoma Steel (ASTL) recorded C$267.5 million in revenue for its second quarter. The brief headline indicates a significant financial update for the company.

Castle Biosciences CEO Maetzold sells $237,682 in company stock

Castle Biosciences CEO Derek J. Maetzold sold $237,682 worth of company stock through direct sales and various trusts on July 27, 2026, under a Rule 10b5-1 trading plan. Despite the sales, Maetzold also acquired 6,214 shares by exercising vested stock options. The company is …

Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells $150,130.24 in Stock

Castle Biosciences (NASDAQ:CSTL) insider Derek Maetzold sold 6,214 shares of the company's stock, totaling $150,130.24, under a pre-arranged Rule 10b5-1 plan. This transaction reduced his ownership by 22.44%. The company's stock was trading up 2.4% at $24.46, and analysts maintain a "Moderate Buy" consensus …

American Tower or Crown Castle? Wall Street's Clear Pick Between Beaten-Down Tower REITs

Wall Street analysts favor American Tower (AMT) over Crown Castle (CCI) among cell-tower REITs, citing AMT's superior growth trajectory, stronger balance sheet, and growing

Algoma Steel Group Inc. Warrant 2021-19.10.26 on Algoma Steel Group Revenue Breakdown – TSX:ASTL.WT

This article provides a revenue breakdown for Algoma Steel Group Inc. Warrant 2021-19.10.26 (TSX:ASTL.WT). For the last year, the company generated 2.09 billion CAD, with its top-performing segment, Sheet & Strip, contributing 1.31 billion CAD. The United States was the largest geographical contributor, accounting …

Algoma Steel Reports Q2 2026 Results, Adjusted EBITDA of $13.8 Million as EAF Ramp-Up and Plate Sales Hit Records

Algoma Steel earnings beat by C$0.03, revenue fell short of estimates

ETFs Investing in Crown Castle Inc. Stocks

This article lists various ETFs that hold stocks of Crown Castle Inc. (CCI), providing details such as market value, weight in the fund, issuer, management style, expense ratio, and 3-year NAV total return. The ETFs cover different investment strategies including passive, active, real estate, …